Additionally, cytokine-driven interactions, such as those involving interferon-gamma and CCL28, in the OR group suggest a more robust immune regulatory environment, corroborating the role of cytokines in MM immune responses (36). This evidence concerns the gene CCL28 and Miyoshi myopathy.